Eucrates Biomedical Acquisition Corp. - FORM S-1/A - EX-23.1 - EXHIBIT 23.1 - October 15, 2020

Attached files

file filename
EX-4.3 - EXHIBIT 4.3 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex4-3.htm
EX-99.2 - EXHIBIT 99.2 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex99-1.htm
EX-14 - EXHIBIT 14 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex14.htm
EX-10.6 - EXHIBIT 10.6 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-6.htm
EX-10.5 - EXHIBIT 10.5 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-1.htm
EX-5.2 - EXHIBIT 5.2 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex5-2.htm
EX-5.1 - EX-5.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex5-1.htm
EX-4.4 - EXHIBIT 4.4 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex4-4.htm
EX-4.2 - EXHIBIT 4.2 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex4-2.htm
EX-4.1 - EXHIBIT 4.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex4-1.htm
EX-3.2 - EXHIBIT 3.2 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex3-1.htm
EX-1.1 - EXHIBIT 1.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex1-1.htm
S-1/A - S-1/A - Eucrates Biomedical Acquisition Corp.tm2029948-5_s1a.htm

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the inclusion in this Registration Statement of Eucrates Biomedical Acquisition Corp. (the “Company”) on Amendment No. 1 to Form S-1 [File No. 333-249333] of our report dated September 1, 2020, which includes an explanatory paragraph as to the Company’s ability to continue as going concern, with respect to our audit of the financial statements of Eucrates Biomedical Acquisition Corp. as of August 25, 2020 and for the period from August 21, 2020 (inception) through August 25, 2020, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.

 

 

/s/ Marcum llp

 

Marcum llp

New York, NY

October 15, 2020

 

 

 

 

 

Eucrates Biomedical Acquisition Corp. Reports